GO:1901576 | organic substance biosynthetic process | 21.84% (19/87) | 3.27 | 0.0 | 0.0 |
GO:0008150 | biological_process | 42.53% (37/87) | 1.96 | 0.0 | 0.0 |
GO:0009059 | macromolecule biosynthetic process | 18.39% (16/87) | 3.59 | 0.0 | 0.0 |
GO:0005575 | cellular_component | 28.74% (25/87) | 2.56 | 0.0 | 0.0 |
GO:0034645 | cellular macromolecule biosynthetic process | 17.24% (15/87) | 3.73 | 0.0 | 0.0 |
GO:0009058 | biosynthetic process | 21.84% (19/87) | 3.16 | 0.0 | 0.0 |
GO:0008152 | metabolic process | 33.33% (29/87) | 2.22 | 0.0 | 0.0 |
GO:0043232 | intracellular non-membrane-bounded organelle | 16.09% (14/87) | 3.71 | 0.0 | 0.0 |
GO:0043228 | non-membrane-bounded organelle | 16.09% (14/87) | 3.71 | 0.0 | 0.0 |
GO:0071704 | organic substance metabolic process | 29.89% (26/87) | 2.22 | 0.0 | 0.0 |
GO:0044260 | cellular macromolecule metabolic process | 17.24% (15/87) | 3.36 | 0.0 | 0.0 |
GO:0005840 | ribosome | 14.94% (13/87) | 3.68 | 0.0 | 0.0 |
GO:0043604 | amide biosynthetic process | 14.94% (13/87) | 3.61 | 0.0 | 0.0 |
GO:0044249 | cellular biosynthetic process | 18.39% (16/87) | 3.1 | 0.0 | 0.0 |
GO:0043043 | peptide biosynthetic process | 14.94% (13/87) | 3.62 | 0.0 | 0.0 |
GO:0034641 | cellular nitrogen compound metabolic process | 19.54% (17/87) | 2.96 | 0.0 | 0.0 |
GO:0003735 | structural constituent of ribosome | 14.94% (13/87) | 3.62 | 0.0 | 0.0 |
GO:0006412 | translation | 14.94% (13/87) | 3.63 | 0.0 | 0.0 |
GO:0006518 | peptide metabolic process | 14.94% (13/87) | 3.56 | 0.0 | 0.0 |
GO:0005198 | structural molecule activity | 14.94% (13/87) | 3.54 | 0.0 | 0.0 |
GO:0043603 | amide metabolic process | 14.94% (13/87) | 3.53 | 0.0 | 0.0 |
GO:0009987 | cellular process | 31.03% (27/87) | 2.04 | 0.0 | 0.0 |
GO:0110165 | cellular anatomical entity | 22.99% (20/87) | 2.53 | 0.0 | 0.0 |
GO:0003674 | molecular_function | 50.57% (44/87) | 1.34 | 0.0 | 0.0 |
GO:0043226 | organelle | 16.09% (14/87) | 3.28 | 0.0 | 0.0 |
GO:0043229 | intracellular organelle | 16.09% (14/87) | 3.28 | 0.0 | 0.0 |
GO:0044238 | primary metabolic process | 27.59% (24/87) | 2.19 | 0.0 | 0.0 |
GO:0043170 | macromolecule metabolic process | 24.14% (21/87) | 2.4 | 0.0 | 0.0 |
GO:0044271 | cellular nitrogen compound biosynthetic process | 16.09% (14/87) | 3.22 | 0.0 | 0.0 |
GO:0044237 | cellular metabolic process | 25.29% (22/87) | 2.3 | 0.0 | 0.0 |
GO:1901564 | organonitrogen compound metabolic process | 22.99% (20/87) | 2.41 | 0.0 | 0.0 |
GO:1901566 | organonitrogen compound biosynthetic process | 14.94% (13/87) | 3.22 | 0.0 | 0.0 |
GO:0019538 | protein metabolic process | 20.69% (18/87) | 2.53 | 0.0 | 0.0 |
GO:0006807 | nitrogen compound metabolic process | 24.14% (21/87) | 2.23 | 0.0 | 0.0 |
GO:0016853 | isomerase activity | 5.75% (5/87) | 4.14 | 1e-05 | 9.2e-05 |
GO:0004347 | glucose-6-phosphate isomerase activity | 2.3% (2/87) | 7.92 | 2.7e-05 | 0.000231 |
GO:0045182 | translation regulator activity | 4.6% (4/87) | 4.36 | 4.6e-05 | 0.000366 |
GO:0008135 | translation factor activity, RNA binding | 4.6% (4/87) | 4.36 | 4.6e-05 | 0.000366 |
GO:0090079 | translation regulator activity, nucleic acid binding | 4.6% (4/87) | 4.36 | 4.6e-05 | 0.000366 |
GO:0032991 | protein-containing complex | 8.05% (7/87) | 2.87 | 5.1e-05 | 0.000392 |
GO:0004864 | protein phosphatase inhibitor activity | 2.3% (2/87) | 7.07 | 9.7e-05 | 0.000708 |
GO:0019212 | phosphatase inhibitor activity | 2.3% (2/87) | 7.07 | 9.7e-05 | 0.000708 |
GO:0035303 | regulation of dephosphorylation | 2.3% (2/87) | 6.54 | 0.000208 | 0.001395 |
GO:0035304 | regulation of protein dephosphorylation | 2.3% (2/87) | 6.54 | 0.000208 | 0.001395 |
GO:0043666 | regulation of phosphoprotein phosphatase activity | 2.3% (2/87) | 6.54 | 0.000208 | 0.001395 |
GO:0010921 | regulation of phosphatase activity | 2.3% (2/87) | 6.54 | 0.000208 | 0.001395 |
GO:0051336 | regulation of hydrolase activity | 2.3% (2/87) | 6.43 | 0.000243 | 0.001591 |
GO:0046364 | monosaccharide biosynthetic process | 2.3% (2/87) | 6.33 | 0.00028 | 0.001724 |
GO:0006094 | gluconeogenesis | 2.3% (2/87) | 6.33 | 0.00028 | 0.001724 |
GO:0019319 | hexose biosynthetic process | 2.3% (2/87) | 6.33 | 0.00028 | 0.001724 |
GO:0003755 | peptidyl-prolyl cis-trans isomerase activity | 3.45% (3/87) | 4.42 | 0.000391 | 0.002317 |
GO:0016859 | cis-trans isomerase activity | 3.45% (3/87) | 4.42 | 0.000391 | 0.002317 |
GO:0019888 | protein phosphatase regulator activity | 2.3% (2/87) | 5.99 | 0.000454 | 0.002638 |
GO:0016860 | intramolecular oxidoreductase activity | 2.3% (2/87) | 5.92 | 0.000504 | 0.002722 |
GO:0019208 | phosphatase regulator activity | 2.3% (2/87) | 5.92 | 0.000504 | 0.002722 |
GO:0006414 | translational elongation | 2.3% (2/87) | 5.92 | 0.000504 | 0.002722 |
GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses | 2.3% (2/87) | 5.92 | 0.000504 | 0.002722 |
GO:0019220 | regulation of phosphate metabolic process | 2.3% (2/87) | 5.72 | 0.000669 | 0.003376 |
GO:0031399 | regulation of protein modification process | 2.3% (2/87) | 5.72 | 0.000669 | 0.003376 |
GO:0051174 | regulation of phosphorus metabolic process | 2.3% (2/87) | 5.72 | 0.000669 | 0.003376 |
GO:0006006 | glucose metabolic process | 2.3% (2/87) | 5.72 | 0.000669 | 0.003376 |
GO:0098772 | molecular function regulator activity | 3.45% (3/87) | 3.91 | 0.001093 | 0.005428 |
GO:0050790 | regulation of catalytic activity | 2.3% (2/87) | 5.33 | 0.001141 | 0.005578 |
GO:0019318 | hexose metabolic process | 2.3% (2/87) | 5.29 | 0.001218 | 0.005864 |
GO:0005996 | monosaccharide metabolic process | 2.3% (2/87) | 5.2 | 0.001381 | 0.006541 |
GO:0044183 | protein folding chaperone | 3.45% (3/87) | 3.76 | 0.001465 | 0.006835 |
GO:0097159 | organic cyclic compound binding | 16.09% (14/87) | 1.28 | 0.001663 | 0.007424 |
GO:1901363 | heterocyclic compound binding | 16.09% (14/87) | 1.28 | 0.001663 | 0.007424 |
GO:0065009 | regulation of molecular function | 2.3% (2/87) | 5.07 | 0.001642 | 0.007548 |
GO:0005839 | proteasome core complex | 2.3% (2/87) | 4.92 | 0.002024 | 0.008906 |
GO:0003746 | translation elongation factor activity | 2.3% (2/87) | 4.85 | 0.00223 | 0.009672 |
GO:0006757 | ATP generation from ADP | 2.3% (2/87) | 4.63 | 0.003022 | 0.011216 |
GO:0009135 | purine nucleoside diphosphate metabolic process | 2.3% (2/87) | 4.63 | 0.003022 | 0.011216 |
GO:0046939 | nucleotide phosphorylation | 2.3% (2/87) | 4.63 | 0.003022 | 0.011216 |
GO:0000413 | protein peptidyl-prolyl isomerization | 2.3% (2/87) | 4.63 | 0.003022 | 0.011216 |
GO:0009185 | ribonucleoside diphosphate metabolic process | 2.3% (2/87) | 4.63 | 0.003022 | 0.011216 |
GO:0006165 | nucleoside diphosphate phosphorylation | 2.3% (2/87) | 4.63 | 0.003022 | 0.011216 |
GO:0046031 | ADP metabolic process | 2.3% (2/87) | 4.63 | 0.003022 | 0.011216 |
GO:0009179 | purine ribonucleoside diphosphate metabolic process | 2.3% (2/87) | 4.63 | 0.003022 | 0.011216 |
GO:0009132 | nucleoside diphosphate metabolic process | 2.3% (2/87) | 4.63 | 0.003022 | 0.011216 |
GO:0018208 | peptidyl-proline modification | 2.3% (2/87) | 4.63 | 0.003022 | 0.011216 |
GO:0006096 | glycolytic process | 2.3% (2/87) | 4.63 | 0.003022 | 0.011216 |
GO:0006090 | pyruvate metabolic process | 2.3% (2/87) | 4.6 | 0.003145 | 0.011532 |
GO:0033177 | proton-transporting two-sector ATPase complex, proton-transporting domain | 2.3% (2/87) | 4.57 | 0.00327 | 0.011848 |
GO:0004857 | enzyme inhibitor activity | 2.3% (2/87) | 4.69 | 0.002784 | 0.01191 |
GO:1902600 | proton transmembrane transport | 2.3% (2/87) | 4.51 | 0.003526 | 0.01263 |
GO:0051246 | regulation of protein metabolic process | 2.3% (2/87) | 4.49 | 0.003658 | 0.012951 |
GO:0005488 | binding | 21.84% (19/87) | 0.93 | 0.004038 | 0.014132 |
GO:0043086 | negative regulation of catalytic activity | 1.15% (1/87) | 7.66 | 0.004953 | 0.014811 |
GO:0051346 | negative regulation of hydrolase activity | 1.15% (1/87) | 7.66 | 0.004953 | 0.014811 |
GO:0031400 | negative regulation of protein modification process | 1.15% (1/87) | 7.66 | 0.004953 | 0.014811 |
GO:0004865 | protein serine/threonine phosphatase inhibitor activity | 1.15% (1/87) | 7.66 | 0.004953 | 0.014811 |
GO:0035305 | negative regulation of dephosphorylation | 1.15% (1/87) | 7.66 | 0.004953 | 0.014811 |
GO:0008154 | actin polymerization or depolymerization | 1.15% (1/87) | 7.66 | 0.004953 | 0.014811 |
GO:0032515 | negative regulation of phosphoprotein phosphatase activity | 1.15% (1/87) | 7.66 | 0.004953 | 0.014811 |
GO:0030041 | actin filament polymerization | 1.15% (1/87) | 7.66 | 0.004953 | 0.014811 |
GO:0010923 | negative regulation of phosphatase activity | 1.15% (1/87) | 7.66 | 0.004953 | 0.014811 |
GO:0045936 | negative regulation of phosphate metabolic process | 1.15% (1/87) | 7.66 | 0.004953 | 0.014811 |
GO:0051258 | protein polymerization | 1.15% (1/87) | 7.66 | 0.004953 | 0.014811 |
GO:0016593 | Cdc73/Paf1 complex | 1.15% (1/87) | 7.66 | 0.004953 | 0.014811 |
GO:0035308 | negative regulation of protein dephosphorylation | 1.15% (1/87) | 7.66 | 0.004953 | 0.014811 |
GO:0010563 | negative regulation of phosphorus metabolic process | 1.15% (1/87) | 7.66 | 0.004953 | 0.014811 |
GO:0005975 | carbohydrate metabolic process | 4.6% (4/87) | 2.55 | 0.005034 | 0.014908 |
GO:0140678 | molecular function inhibitor activity | 2.3% (2/87) | 4.24 | 0.005099 | 0.014956 |
GO:0016052 | carbohydrate catabolic process | 2.3% (2/87) | 4.26 | 0.004945 | 0.017112 |
GO:0003743 | translation initiation factor activity | 2.3% (2/87) | 4.13 | 0.005902 | 0.017149 |
GO:0018193 | peptidyl-amino acid modification | 2.3% (2/87) | 4.11 | 0.006069 | 0.017469 |
GO:0016051 | carbohydrate biosynthetic process | 2.3% (2/87) | 4.09 | 0.006238 | 0.01779 |
GO:0016125 | sterol metabolic process | 1.15% (1/87) | 7.24 | 0.006599 | 0.017828 |
GO:0006368 | transcription elongation by RNA polymerase II | 1.15% (1/87) | 7.24 | 0.006599 | 0.017828 |
GO:0008023 | transcription elongation factor complex | 1.15% (1/87) | 7.24 | 0.006599 | 0.017828 |
GO:0006354 | DNA-templated transcription elongation | 1.15% (1/87) | 7.24 | 0.006599 | 0.017828 |
GO:0016126 | sterol biosynthetic process | 1.15% (1/87) | 7.24 | 0.006599 | 0.017828 |
GO:1901360 | organic cyclic compound metabolic process | 5.75% (5/87) | 2.1 | 0.006461 | 0.018258 |
GO:0043168 | anion binding | 9.2% (8/87) | 1.5 | 0.007362 | 0.019718 |
GO:0140535 | intracellular protein-containing complex | 2.3% (2/87) | 3.92 | 0.007857 | 0.020861 |
GO:0045048 | protein insertion into ER membrane | 1.15% (1/87) | 6.92 | 0.008241 | 0.021331 |
GO:0001671 | ATPase activator activity | 1.15% (1/87) | 6.92 | 0.008241 | 0.021331 |
GO:0051205 | protein insertion into membrane | 1.15% (1/87) | 6.92 | 0.008241 | 0.021331 |
GO:0098655 | monoatomic cation transmembrane transport | 2.3% (2/87) | 3.87 | 0.008434 | 0.021647 |
GO:0051603 | proteolysis involved in protein catabolic process | 2.3% (2/87) | 3.78 | 0.009437 | 0.024021 |
GO:0034220 | monoatomic ion transmembrane transport | 2.3% (2/87) | 3.76 | 0.009643 | 0.024345 |
GO:0016628 | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor | 1.15% (1/87) | 6.66 | 0.009882 | 0.024744 |
GO:0098662 | inorganic cation transmembrane transport | 2.3% (2/87) | 3.7 | 0.01049 | 0.025847 |
GO:0036094 | small molecule binding | 9.2% (8/87) | 1.41 | 0.01043 | 0.025907 |
GO:0035639 | purine ribonucleoside triphosphate binding | 8.05% (7/87) | 1.52 | 0.011196 | 0.027151 |
GO:0032787 | monocarboxylic acid metabolic process | 2.3% (2/87) | 3.66 | 0.011146 | 0.027245 |
GO:0098660 | inorganic ion transmembrane transport | 2.3% (2/87) | 3.64 | 0.011368 | 0.027355 |
GO:0006091 | generation of precursor metabolites and energy | 2.3% (2/87) | 3.61 | 0.011819 | 0.028219 |
GO:0015078 | proton transmembrane transporter activity | 2.3% (2/87) | 3.6 | 0.012047 | 0.028543 |
GO:0030234 | enzyme regulator activity | 2.3% (2/87) | 3.57 | 0.01251 | 0.029413 |
GO:0005852 | eukaryotic translation initiation factor 3 complex | 1.15% (1/87) | 6.24 | 0.013154 | 0.02979 |
GO:0044092 | negative regulation of molecular function | 1.15% (1/87) | 6.24 | 0.013154 | 0.02979 |
GO:0051248 | negative regulation of protein metabolic process | 1.15% (1/87) | 6.24 | 0.013154 | 0.02979 |
GO:0050997 | quaternary ammonium group binding | 1.15% (1/87) | 6.24 | 0.013154 | 0.02979 |
GO:0030976 | thiamine pyrophosphate binding | 1.15% (1/87) | 6.24 | 0.013154 | 0.02979 |
GO:0009199 | ribonucleoside triphosphate metabolic process | 2.3% (2/87) | 3.49 | 0.013943 | 0.030676 |
GO:0009144 | purine nucleoside triphosphate metabolic process | 2.3% (2/87) | 3.49 | 0.013943 | 0.030676 |
GO:0046034 | ATP metabolic process | 2.3% (2/87) | 3.49 | 0.013943 | 0.030676 |
GO:0009205 | purine ribonucleoside triphosphate metabolic process | 2.3% (2/87) | 3.49 | 0.013943 | 0.030676 |
GO:0009141 | nucleoside triphosphate metabolic process | 2.3% (2/87) | 3.46 | 0.014436 | 0.031313 |
GO:0032555 | purine ribonucleotide binding | 8.05% (7/87) | 1.45 | 0.014371 | 0.031392 |
GO:0015629 | actin cytoskeleton | 1.15% (1/87) | 6.07 | 0.014786 | 0.031626 |
GO:0016209 | antioxidant activity | 2.3% (2/87) | 3.45 | 0.014686 | 0.031631 |
GO:0032553 | ribonucleotide binding | 8.05% (7/87) | 1.43 | 0.015511 | 0.032948 |
GO:0022607 | cellular component assembly | 2.3% (2/87) | 3.39 | 0.015701 | 0.033123 |
GO:0008202 | steroid metabolic process | 1.15% (1/87) | 5.92 | 0.016416 | 0.034162 |
GO:0006694 | steroid biosynthetic process | 1.15% (1/87) | 5.92 | 0.016416 | 0.034162 |
GO:0097367 | carbohydrate derivative binding | 8.05% (7/87) | 1.41 | 0.016613 | 0.03434 |
GO:0043167 | ion binding | 11.49% (10/87) | 1.11 | 0.017234 | 0.035388 |
GO:0051172 | negative regulation of nitrogen compound metabolic process | 1.15% (1/87) | 5.78 | 0.018042 | 0.03656 |
GO:0031324 | negative regulation of cellular metabolic process | 1.15% (1/87) | 5.78 | 0.018042 | 0.03656 |
GO:0006139 | nucleobase-containing compound metabolic process | 4.6% (4/87) | 1.99 | 0.018707 | 0.037658 |
GO:0140662 | ATP-dependent protein folding chaperone | 2.3% (2/87) | 3.24 | 0.019202 | 0.038404 |
GO:0016721 | oxidoreductase activity, acting on superoxide radicals as acceptor | 1.15% (1/87) | 5.66 | 0.019667 | 0.038582 |
GO:0004784 | superoxide dismutase activity | 1.15% (1/87) | 5.66 | 0.019667 | 0.038582 |
GO:0019693 | ribose phosphate metabolic process | 2.3% (2/87) | 3.21 | 0.020053 | 0.038601 |
GO:0009150 | purine ribonucleotide metabolic process | 2.3% (2/87) | 3.21 | 0.020053 | 0.038601 |
GO:0009259 | ribonucleotide metabolic process | 2.3% (2/87) | 3.21 | 0.020053 | 0.038601 |
GO:0017076 | purine nucleotide binding | 8.05% (7/87) | 1.36 | 0.019665 | 0.039076 |
GO:0045010 | actin nucleation | 1.15% (1/87) | 5.54 | 0.021288 | 0.039738 |
GO:0034314 | Arp2/3 complex-mediated actin nucleation | 1.15% (1/87) | 5.54 | 0.021288 | 0.039738 |
GO:0005885 | Arp2/3 protein complex | 1.15% (1/87) | 5.54 | 0.021288 | 0.039738 |
GO:0007015 | actin filament organization | 1.15% (1/87) | 5.54 | 0.021288 | 0.039738 |
GO:0097435 | supramolecular fiber organization | 1.15% (1/87) | 5.54 | 0.021288 | 0.039738 |
GO:0004602 | glutathione peroxidase activity | 1.15% (1/87) | 5.43 | 0.022907 | 0.042248 |
GO:0005856 | cytoskeleton | 1.15% (1/87) | 5.43 | 0.022907 | 0.042248 |
GO:0006163 | purine nucleotide metabolic process | 2.3% (2/87) | 3.05 | 0.024534 | 0.043933 |
GO:0006812 | monoatomic cation transport | 2.3% (2/87) | 3.05 | 0.024534 | 0.043933 |
GO:0044283 | small molecule biosynthetic process | 2.3% (2/87) | 3.06 | 0.024224 | 0.04441 |
GO:0048523 | negative regulation of cellular process | 1.15% (1/87) | 5.33 | 0.024523 | 0.04443 |
GO:0009966 | regulation of signal transduction | 1.15% (1/87) | 5.33 | 0.024523 | 0.04443 |
GO:1901265 | nucleoside phosphate binding | 8.05% (7/87) | 1.28 | 0.025364 | 0.044641 |
GO:0000166 | nucleotide binding | 8.05% (7/87) | 1.28 | 0.025364 | 0.044641 |
GO:0072521 | purine-containing compound metabolic process | 2.3% (2/87) | 3.03 | 0.02516 | 0.044793 |
GO:0023051 | regulation of signaling | 1.15% (1/87) | 5.24 | 0.026137 | 0.045226 |
GO:0010646 | regulation of cell communication | 1.15% (1/87) | 5.24 | 0.026137 | 0.045226 |
GO:0046483 | heterocycle metabolic process | 4.6% (4/87) | 1.83 | 0.026288 | 0.045233 |
GO:0006725 | cellular aromatic compound metabolic process | 4.6% (4/87) | 1.84 | 0.026042 | 0.045574 |
GO:1901617 | organic hydroxy compound biosynthetic process | 1.15% (1/87) | 5.15 | 0.027748 | 0.047217 |
GO:0051087 | chaperone binding | 1.15% (1/87) | 5.15 | 0.027748 | 0.047217 |
GO:0009117 | nucleotide metabolic process | 2.3% (2/87) | 2.93 | 0.028716 | 0.048597 |
GO:0006753 | nucleoside phosphate metabolic process | 2.3% (2/87) | 2.91 | 0.029384 | 0.04892 |
GO:0016226 | iron-sulfur cluster assembly | 1.15% (1/87) | 5.07 | 0.029356 | 0.04914 |
GO:0031163 | metallo-sulfur cluster assembly | 1.15% (1/87) | 5.07 | 0.029356 | 0.04914 |